HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reversal of lead-induced neuronal apoptosis by chelation treatment in rats: role of reactive oxygen species and intracellular Ca(2+).

Abstract
Lead, a ubiquitous and potent neurotoxicant causes several neurophysiological and behavioral alterations. Toxic properties of lead have been attributed to its capability to mimic calcium and alter calcium homeostasis. In this study, we have addressed the following issues: 1) whether chelation therapy could circumvent the altered Ca(2+) homeostasis and prevent neuronal death in chronic lead-intoxicated rats, 2) whether chelation therapy could revert altered biochemical and behavioral changes, 3) whether combinational therapy using two different chelating agents was more advantageous over monotherapy in lead-treated rats, and 4) what could be the mechanism of neuronal apoptosis. Results indicated that lead caused a significant increase in reactive oxygen species, neuronal nitric-oxide synthetase, and intracellular free calcium levels along with altered behavioral abnormalities in locomotor activity, exploratory behavior, learning, and memory that were supported by changes in neurotransmitter levels. A fall in membrane potential, release of cytochrome c, and altered bcl(2)/bax ratio indicated mitochondrial-dependent apoptosis. Most of these alterations reverted toward normal level following combination therapy over monotherapy with calcium disodium EDTA (CaNa(2)EDTA) or monoisoamyl meso-2,3-dimercaptosuccinic acid (MiADMSA). It could be concluded from our present results that combined therapy with CaNa(2)EDTA and MiADMSA might be a better treatment protocol than monotherapy with these chelators in lead-induced neurological disorders. We for the first time report the role of Ca(2+) in regulating neurological dystrophy caused by chronic lead exposure in rats and its recovery with a two-course treatment regime of mono or combination therapy.
AuthorsSwaran J S Flora, Geetu Saxena, Ashish Mehta
JournalThe Journal of pharmacology and experimental therapeutics (J Pharmacol Exp Ther) Vol. 322 Issue 1 Pg. 108-16 (Jul 2007) ISSN: 0022-3565 [Print] United States
PMID17431133 (Publication Type: Journal Article)
Chemical References
  • Chelating Agents
  • Neurotransmitter Agents
  • Reactive Oxygen Species
  • Lead
  • Edetic Acid
  • monoisoamyl-2,3-dimercaptosuccinate
  • Succimer
  • Calcium
Topics
  • Animals
  • Apoptosis (drug effects)
  • Behavior, Animal (drug effects)
  • Brain (metabolism)
  • Calcium (metabolism)
  • Chelating Agents (pharmacology)
  • Edetic Acid (pharmacology)
  • Lead (toxicity)
  • Male
  • Mitochondria (drug effects)
  • Neurons (cytology, drug effects)
  • Neurotransmitter Agents (analysis)
  • Oxidative Stress
  • Rats
  • Rats, Wistar
  • Reactive Oxygen Species (metabolism)
  • Succimer (analogs & derivatives, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: